Health
1 read
FDA Approves New Gene Therapy for Sickle Cell Disease in Children

Want the full story?
Read the complete article at KTSM
AI Summary
The U.S. Food and Drug Administration has granted approval for a groundbreaking gene therapy aimed at treating children aged 2 and older suffering from sickle cell disease. This new treatment represents a significant advancement in managing this chronic condition, which affects the shape and function of red blood cells, leading to severe pain and health complications. The approval is expected to provide new hope for affected families and improve the quality of life for children dealing with this debilitating illness. Parents and healthcare providers should stay informed about the availability and administration of this therapy.
health fda children gene-therapy sickle-cell
People & Organizations
U.S. Food and Drug Administration